Introduction. BNP plasma levels are significantly increased in heart failure and have an excellent negative predictive value for left ventricular dysfunction. Measurement of BNP level is useful for “screening” in high-risk populations. It is suitable for detection of left ventricular hypertrophy (LVH) and/or dysfunction and risk assessment in the sub-acute phase of acute myocardial infarction in hypertensive patients. The aim of our study was to find whether BNP may correlate with the left ventricular systolic function, i.e. its echocardiographic parameters in chronic kidney disease (CKD) patients
Anemia is common in patients with chronic kidney disease (CKD) and contributes to cardiovascular alt...
Aims. This study was performed to evaluate the relationship between three different natriuretic pept...
Background: The diagnostic value of natriuretic pep-tides in uremic cardiomyopathy has not been defi...
Background. Measurement of natriuretic peptides, particularly brain natriuretic peptide (BNP) is an ...
We evaluated the cross-sectional associations of N-terminal pro-B-type natriuretic peptide (NT-proBN...
Chronic kidney disease (CKD) and congestive heart failure (CHF) are epidemiologically and pathophysi...
Diagnostic potential of cardiac natriuretic peptides in dialysis patients.BackgroundIn the general p...
Diabetic patients with chronic renal failure (CRF) have been reported to start hemodialysis (HD) ear...
Background: The widespread use of brain natriuretic peptide testing among patients with end-stage ki...
Introduction: Chronic kidney disease (CKD) and congestive heart failure (CHF) patients have higher s...
Background. As a cardiorenal syndrome, there is a dynamic interplay between the heart and the kidney...
Introduction: The significance of N-terminal pro-B type natriuretic peptide (NT-proBNP) to detect he...
Natriuretic peptides (NP), especially B type (BNP) and its N-terminal pro-B type natriuretic peptide...
Dialysis patients suffer a greatly heightened risk of cardiovascular morbidity and mortality. These ...
Circulating biomarkers play a major role in the early detection of cardiovascular di-sease. The purp...
Anemia is common in patients with chronic kidney disease (CKD) and contributes to cardiovascular alt...
Aims. This study was performed to evaluate the relationship between three different natriuretic pept...
Background: The diagnostic value of natriuretic pep-tides in uremic cardiomyopathy has not been defi...
Background. Measurement of natriuretic peptides, particularly brain natriuretic peptide (BNP) is an ...
We evaluated the cross-sectional associations of N-terminal pro-B-type natriuretic peptide (NT-proBN...
Chronic kidney disease (CKD) and congestive heart failure (CHF) are epidemiologically and pathophysi...
Diagnostic potential of cardiac natriuretic peptides in dialysis patients.BackgroundIn the general p...
Diabetic patients with chronic renal failure (CRF) have been reported to start hemodialysis (HD) ear...
Background: The widespread use of brain natriuretic peptide testing among patients with end-stage ki...
Introduction: Chronic kidney disease (CKD) and congestive heart failure (CHF) patients have higher s...
Background. As a cardiorenal syndrome, there is a dynamic interplay between the heart and the kidney...
Introduction: The significance of N-terminal pro-B type natriuretic peptide (NT-proBNP) to detect he...
Natriuretic peptides (NP), especially B type (BNP) and its N-terminal pro-B type natriuretic peptide...
Dialysis patients suffer a greatly heightened risk of cardiovascular morbidity and mortality. These ...
Circulating biomarkers play a major role in the early detection of cardiovascular di-sease. The purp...
Anemia is common in patients with chronic kidney disease (CKD) and contributes to cardiovascular alt...
Aims. This study was performed to evaluate the relationship between three different natriuretic pept...
Background: The diagnostic value of natriuretic pep-tides in uremic cardiomyopathy has not been defi...